Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17701
Baseline characteristics of the subjects.
Published 2025“…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
-
17702
Knockdown of nr2f1a causes defects in zebrafish vascular development.
Published 2014“…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a ∼50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
-
17703
Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies
Published 2014“…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
-
17704
-
17705
-
17706
-
17707
S2 Data -
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
17708
Study protocol.
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
17709
S1 Data -
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
17710
-
17711
-
17712
-
17713
Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial
Published 2016“…The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. …”
-
17714
-
17715
Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease
Published 2018“…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”
-
17716
Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering.
Published 2013“…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”
-
17717
-
17718
CCBs preserve normal R<sub>in</sub> against EC-Aβ in the granule cells.
Published 2015“…<p>A, R<sub>in</sub> was significantly decreased in the granule cells from Aβ treated rats compared to the control group. …”
-
17719
Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg
Published 2023“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
-
17720
Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg
Published 2023“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”